Cases Age (yo) Gender Histology Path Staging Initial tumor size (cm) Final Tumor size (cm) % Difference Path Staging
1 63 Male RCC-CC pT2N0 16.07 15.59 -3% pT2pN0
2 46 Female RCC-CC pT3aN0 16.52 13.15 -20% pT3apN0
3 55 Female RCC-Papillary pT2aN0 15.11 10.05 -33.5% pT2apN0
4 45 Female RCC-XP11.2 pT2aN0 14.32 14.74 +3.0% pT2apN0
5 51 Female RCC-CC pT2aN0 18.34 15.25 -16.8% pT2apN0
controls  
1 61 Male RCC-CC pT1bN0 6.00      
2 62 Male RCC-CC pT2N0 9.50      
3 68 Male RCC-CC pT1aN0 3.50      
4 57 Male RCC-CC pT2N2 8.50      
5 59 Male RCC-CC pT3bN0 10.50      
6 59 Female RCC-CC pT3aN0 15.60      
RCC: Renal Cell Carcinoma; CC: Clear Cell
Table 1: Summary of the cohort of patients who took part in this study.